Yourway
Trending Articles
Related Content
Regulatory
Supporting global decentralised and virtual clinical trials during challenging times and beyond
Decentralised clinical trials (DCTs) utilising direct-to-patient (DTP) services, including the provision of drug products, ancillary supplies and home healthcare visits, have demonstrated significant benefits in terms of patient recruitment, enrolment and reducing burdens on participants. Additionally, they have facilitated trials investigating rare diseases with geographically dispersed populations and other challenges that were previously impossible.
Manufacturing
Yourway breaks ground on major expansion in Pennsylvania
The expansion will significantly extend Yourway’s temperature-controlled storage capacity, including 15–25 °C, 2–8 °C, –20 °C, –80 °C, and –180 °C, addressing the growing need for temperature-controlled services for clinical trials involving biologics, cell and gene therapies, and other advanced modalities
Regulatory
Advances in technology and support for Direct-To-Patient (DTP) services
Although the emergence of COVID-19 has led to an industry wide uptake of decentralised clinical trial models — including DTP and direct-from-patient (DFP) supply and healthcare services — the pandemic has also introduced novel challenges and complications in terms of DTP/DFP logistics,<sup>1</sup> reports Leandro Moreira, SVP of Corporate Development, Yourway
Packaging
Expediting clinical trials with a global transportation footprint and clinical packaging
Clinical trials are increasingly global and include both traditional structures and newer site-free models with direct-to- and direct-from-patient delivery capabilities, reports Gulam Jaffer, President at Yourway